Sarcopenia: Molecular Pathways and Potential Targets for Intervention
Open accessThe DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Abstract
Aging is associated with sarcopenia. The loss of strength results in decreased muscle mass and motor function. This process accelerates the progressive muscle deterioration observed in older adults, favoring the presence of debilitating pathologies. In addition, sarcopenia leads to a decrease in quality of life, significantly affecting self-sufficiency. Altogether, these results in an increase in economic resources from the National Health Systems devoted to mitigating this problem in the elderly, particularly in developed countries. Different etiological determinants are involved in the progression of the disease, including: neurological factors, endocrine alterations, as well as nutritional and lifestyle changes related to the adoption of more sedentary habits. Molecular and cellular mechanisms have not been clearly characterized, resulting in the absence of an effective treatment for sarcopenia. Nevertheless, physical activity seems to be the sole strategy to delay sarcopenia and its symptoms. The present review intends to bring together the data explaining how physical activity modulates at a molecular and cellular level all factors that predispose or favor the progression of this deteriorating pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite the fact that the effect of Ang-(1-7) has not been directly assayed in SO, the mechanisms involved in muscle mass regulation include decreased protein degradation, prevention of Os, apoptosis, and mitochondrial dysfunction.”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [146]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818 · cited 1×
“Therefore, sarcopenia appears at a moment in life when physical activity decreases considerably [16], which could be one of the main triggers for the aforementioned events.”
BackgroundSarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601 · cited 4×
“Furthermore, this degenerative process can exacerbate other underlying conditions, and ultimately cause a decrease in life expectancy [2,3].”
BackgroundInfluentialMassagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556 · cited 2×
“In the case of myostatin, its activation requires the participation of ActRIIB (activin receptor IIB) and ALK4 (activin-like kinase 4), both of which are also involved in activin signaling [36].”
BackgroundCruz-Jentoft, A. J., & Sayer, A. A. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31138-9 · Cited by 3,905
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Fielding, R. A., Vellas, B., Evans, W. J., Bhasin, S., Morley, J. E., Newman, A. B., Abellan van Kan, G., Andrieu, S., Bauer, J., Breuille, D., et al. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.01.003 · Cited by 3,256 · cited 1×
“Changes are observed both in fiber size and number, particularly type II fibers [17].”
BackgroundSandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012 · cited 1×
“Alterations in the transcriptional regulation at the myocyte level have been proposed, triggering the activation of proteolytic processes [30].”
BackgroundExercise-Induced Oxidative Stress: Cellular Mechanisms and Impact on Muscle Force Production
Powers, S. K., & Jackson, M. J. (2008) · Physiological Reviews · doi:10.1152/physrev.00031.2007 · Cited by 2,459 · cited 13×
“Since this response is mitigated in aged muscle tissue, we can hypothesize that the overproduction of RONS together with a decreased response from antioxidant systems could contribute to the appearance of sarcopenia and delay of muscle regeneration in the elderly [52].”
BackgroundInfluentialPeroxynitrite: biochemistry, pathophysiology and development of therapeutics
Szabó, C., Ischiropoulos, H., & Radi, R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2222 · Cited by 2,134
Cited by
Mitochondrial dysfunction: roles in skeletal muscle atrophy
Chen, X., Ji, Y., Liu, R., Zhu, X., Wang, K., Yang, X., Liu, B., Gao, Z., Huang, Y., Shen, Y., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04369-z · Cited by 317
“ROS, a by-product of mitochondrial metabolism, causes progressive damage to key cellular macromolecules (lipids, proteins and DNAs), and skeletal muscle is particularly susceptible due to its high metabolic rate [35].”
BackgroundSarcopenia in the Older Adult With Cancer
Williams, G. R., Dunne, R. F., Giri, S., Shachar, S. S., & Caan, B. J. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.00102 · Cited by 248
Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease
Lim, S., Kim, J.-W., & Targher, G. (2021) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2021.04.008 · Cited by 213
Liu, D., Wang, S., Liu, S., Wang, Q., Che, X., & Wu, G. (2024) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2024.101270 · Cited by 168
Sarcopenia in Menopausal Women: Current Perspectives
Buckinx, F., & Aubertin‐Leheudre, M. (2022) · International Journal of Women s Health · doi:10.2147/ijwh.s340537 · Cited by 173
TNF-α contributes to sarcopenia through caspase-8/caspase-3/GSDME-mediated pyroptosis
Wu, J., Lin, S., Chen, W., Lian, G., Wu, W., Chen, A., Sagor, M. I. H., Luo, L., Wang, H., & Xie, L. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01365-6 · Cited by 133
“TNF-α has been validated to participate in the pathogenesis of sarcopenia through its complex intracellular signals [6, 23, 24].”
BackgroundLuo, Y., Zhou, X., Tian, H., Yang, L., Zhu, Y.-H., Hu, P., & Yao, X. (2024) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13541 · Cited by 108
Cellular Senescence in Sarcopenia: Possible Mechanisms and Therapeutic Potential
He, Y., Xie, W., Li, H., Jin, H., Zhang, Y., & Li, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.793088 · Cited by 95
The critical role of oxidative stress in sarcopenic obesity
Gonzalez, A., Simon, F., Achiardi, O., Vilos, C., Cabrera, D., & Cabello-Verrugio, C. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/4493817 · Cited by 79
Exercise and mitochondrial mechanisms in patients with sarcopenia
Pahlavani, H. A., Laher, I., Knechtle, B., & Zouhal, H. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1040381 · Cited by 81
“However, exercise-induced increases in CAT and SOD coincide with elevations in H2O2 and O2 levels, respectively (Pascual-Fernández et al., 2020).”
BackgroundSarcopenia: What Is the Origin of This Aging-Induced Disorder?
Gustafsson, T. P., & Ulfhake, B. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.688526 · Cited by 81
Cacciatore, S., Calvani, R., Marzetti, E., Picca, A., Coelho‐Júnior, H. J., Martone, A. M., Massaro, C., Tosato, M., & Landi, F. (2023) · Nutrients · doi:10.3390/nu15041026 · Cited by 77
Molecular Mechanism and Pathogenesis of Sarcopenia: An Overview
Picca, A., & Calvani, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063032 · Cited by 77
“Exercise training under different regimens is among the few effective strategies for preserving muscle health in old age by regulating several processes at molecular, cellular, and organismal levels [16,17].”
BackgroundInsights into Pathogenesis, Nutritional and Drug Approach in Sarcopenia: A Systematic Review
Mellem, R. H., Girotto, O. S., Marques, E. B., Laurindo, L. F., Grippa, P. C., Mendes, C. G., Garcia, L. N. H., Bechara, M. D., Barbalho, S. M., Sinatora, R. V., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11010136 · Cited by 76
“Therefore, this pro-inflammatory and anti-inflammatory imbalance results in chronic muscle inflammation that can cause damage, such as muscle deterioration [58].”
Guo, B., Liu, X., Si, Q., Zhang, D., Li, M., Li, X., Zhao, Y., Hu, F., Zhang, M., Liu, Y., et al. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-05012-2 · Cited by 80
“Furthermore, sarcopenia imparts a spectrum of physical and functional limitations, exerting a profound impact on an individual’s quality of life and the ability to perform routine activities [2, 3].”
BackgroundReactive oxygen species in the pathogenesis of sarcopenia
Xu, H., Brown, J. L., Bhaskaran, S., & Van Remmen, H. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.11.046 · Cited by 61
“Skeletal muscle is particularly susceptible to ROS-mediated dysfunction due to its high metabolic rate [117].”
The role of TGF-β signaling in muscle atrophy, sarcopenia and cancer cachexia
Lan, X., Deng, C., Wang, Q., Zhao, L., Jiao, B., & Xiang, Y. (2024) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2024.114513 · Cited by 66
Livshits, G., & Kalinkovich, A. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101852 · Cited by 58
Sarcopenia: Molecular regulatory network for loss of muscle mass and function
Wu, J., Ding, P., Wu, H., Yang, P., Guo, H., Tian, Y., Meng, L., & Zhao, Q. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1037200 · Cited by 64
“stress, and promote the proliferation of satellite cells, thus delaying the development of sarcopenia (88).”
BackgroundDiagnostics of inflammaging in relation to sarcopenia
Morawin, B., Tylutka, A., Bielewicz, F., & Zembroń-Łacny, A. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1162385 · Cited by 58
Bile Acids Induce Alterations in Mitochondrial Function in Skeletal Muscle Fibers
Ábrigo, J., Olguín, H. C., Gutiérrez, D., Tacchi, F., Arrese, M. A., Cabrera, D., Valero‐Breton, M., Elorza, Á. A., Simón, F., & Cabello‐Verrugio, C. (2022) · Antioxidants · doi:10.3390/antiox11091706 · Cited by 52
“apoptosis, and mitochondrial dysfunction [2].”
Molecular Mechanisms Underlying Intensive Care Unit-Acquired Weakness and Sarcopenia
Káňová, M., & Kohout, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158396 · Cited by 58
Nunes-Pinto, M., de Mello, R. G. B., Pinto, M. N., Moro, C., Vellas, B. J., Martinez, L. O., Rolland, Y., & Barreto, P. D. S. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102587 · Cited by 61
Huang, Y., Wang, C., Cui, H., Sun, G., Qi, X., & Yao, X. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1590524 · Cited by 61
L-Citrulline Supplementation and Exercise in the Management of Sarcopenia
Caballero-García, A., Pascual-Fernández, J., Noriega, D. C., Bello, H. J., Pons, A., Roche, E., & Córdova, A. (2021) · Nutrients · doi:10.3390/nu13093133 · Cited by 51
“Therefore, considering these muscle markers as indicators of muscle status, they are very useful to follow the evolution of sarcopenia just using the regular blood analysis performed usually in laboratories and health centres [36].”
BackgroundSelf-citationAugmented temperature fluctuation aggravates muscular atrophy through the gut microbiota
Liu, Y., Guo, Y., Liu, Z., Xu, F., Zhou, R., He, Y., Zhou, H., Peng, H., & Huang, Y. (2023) · Nature Communications · doi:10.1038/s41467-023-39171-4 · Cited by 44
“Multiple factors contribute to sarcopenia, including mitochondrial dysfunction, reduced motor unit and satellite cell number, altered proteostasis, enhanced in fl ammation 15,16 , etc. Increasing evidence reveals that gut microbiota is involved in the onset of sarcopenia.”
Correlation between sarcopenia and esophageal cancer: a narrative review
Li, S., Xie, K., Xiao, X., Xu, P., Tang, M., & Li, D. (2024) · World Journal of Surgical Oncology · doi:10.1186/s12957-024-03304-w · Cited by 48
“Certain nutritional interventions, such as the consumption of high-protein or essential amino acids like leucine, in conjunction with resistance training, have the potential to delay skeletal muscle loss observed in sarcopenia [119].”
BackgroundInfluentialAssociations between sarcopenia with asthmatic prevalence, lung function and comorbidity
Hu, Z., Tian, Y., Song, X., Zeng, F., & Yang, A. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-03394-9 · Cited by 40
A review of the components of exercise prescription for sarcopenic older adults
Kumar, P., Umakanth, S., & Girish, N. (2022) · European Geriatric Medicine · doi:10.1007/s41999-022-00693-7 · Cited by 37
Huston, P. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.904107 · Cited by 43
“And there have been new insights into the muscle denervation process that occurs with aging and why once sarcopenia is established, it becomes increasingly challenging to stop (Pascual-Fernández, 2020; Gustaffson and Ulfhake, 2021).”
BackgroundPark, S. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.09.003 · Cited by 31
Salucci, S., Bartoletti‐Stella, A., Bavelloni, A., Aramini, B., Blalock, W. L., Fabbri, F., Vannini, I., Sambri, V., Stella, F., & Faenza, I. (2022) · Nutrients · doi:10.3390/nu14173567 · Cited by 32
Ginseng and ginsenosides: Therapeutic potential for sarcopenia
Zha, W., Sun, Y., Gong, W., Li, L., Kim, W., & Li, H. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113876 · Cited by 33
Xie, S., & Wu, Q. (2024) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-024-04808-7 · Cited by 35
“From the age of 50, muscle loss is estimated to be approximately 0.8% per year, which accelerates to approximately 2% per year starting from the age of 60 [46].”
BackgroundInfluentialNavigating the Intersection: Sarcopenia and Sarcopenic Obesity in Inflammatory Bowel Disease
Calvez, V., Becherucci, G., Covello, C., Piccirilli, G., Mignini, I., Esposto, G., Laterza, L., Ainora, M. E., Scaldaferri, F., Gasbarrini, A., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12061218 · Cited by 32
Araújo, L. P., Godoy, A. C. F., Frota, F. F., Lamas, C. B., Quesada, K. R., Detregiachi, C. R. P., Araújo, A. C., Miglino, M. A., Guiguer, É. L., Haber, R. S. D. A., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262412147 · Cited by 40
“…with the development of sarcopenia and is present in several chronic pathologies; that is, it is a gateway for the appearance of risk factors, such as malnutrition, obesity, anabolic resistance, and mitochondrial damage, which can induce sarcopenia, especially in older individuals [54,55].”
Long, Y., Chow, S. K., Cui, C., Wong, R. M. Y., Zhang, N., Qin, L., Law, S. W., & Cheung, W. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102048 · Cited by 26
Liang, Z., & Zhang, L. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1733798 · Cited by 39
Biomarkers of sarcopenia: an unmet need
Sebaie, M. A. E., & Elwakil, W. (2023) · Egyptian Rheumatology and Rehabilitation · doi:10.1186/s43166-023-00213-w · Cited by 27
“The process of muscle loss involves a significant decline in protein regeneration coupled with an accelerated protein lysis and apoptosis [19–21].”
BackgroundZhang, Y., Liu, K., Zhan, Y., Zhao, Y., Chai, Y., Ning, J., Pan, H., Kong, L., & Yuan, W.-A. (2024) · Phytotherapy Research · doi:10.1002/ptr.8154 · Cited by 25
“…by which Chinese herbal medicine affects sarcopenia is not yet clear, and it may be related to enhancing neural recruitment, maintaining protein homeostasis, regulating satellite cell function, reducing autophagy and inflammation (Fernández-Lázaro et al., 2022; Pascual-Fernández et al., 2020).”
Backgroundl-Arginine and Beetroot Extract Supplementation in the Prevention of Sarcopenia
Córdova-Martínez, A., Caballero-García, A., Bello, H. J., Pons-Biescas, A., Noriega, D. C., & Roche, E. (2022) · Pharmaceuticals · doi:10.3390/ph15030290 · Cited by 21
Self-citationAcute Sarcopenia after Elective and Emergency Surgery
Shrestha, A., Dani, M., Kemp, P. R., & Fertleman, M. B. (2022) · Aging and Disease · doi:10.14336/ad.2022.0404 · Cited by 26
“cytokines IL-6 and TNF-, compared to those without sarcopenia [18], and observational studies have shown these cytokines are associated with future muscle loss [19].”
BackgroundVerschueren, A., Palminha, C., Delmont, É., & Attarian, S. (2022) · Revue Neurologique · doi:10.1016/j.neurol.2022.03.019 · Cited by 21
A nomogram to predict the risk of sarcopenia in older people
Yin, G., Li, H., Li, R., Wang, Z., Lv, F., Qin, J., & Ye, X. (2023) · Medicine · doi:10.1097/md.0000000000033581 · Cited by 21
“[6] Older adults are presented with low-grade chronic inflammatory manifestations that increase sensitivity to sarcopenia.”
Association between daily sitting time and sarcopenia in the US population: a cross-sectional study
Zhang, A., Li, Y., Zhou, J., Zhang, Y., Xie, S., Shao, H., Zhao, T., & Tang, T. (2025) · Archives of Public Health · doi:10.1186/s13690-025-01501-x · Cited by 17
Molecular insights into sarcopenia: ferroptosis-related genes as diagnostic and therapeutic targets
Chen, Y., Zhang, Y., Zhang, S., & Ren, H. (2024) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2298390 · Cited by 16
“Genetic factors serve as a key point in the progression of sarcopenia (Pascual-Fern � andez et al., 2020).”
Adverse childhood experiences, sarcopenia, and social participation in older adults: a cohort study
Huang, R., Li, Y., Ma, C., Ren, R. C., Yuan, X., Peng, Y., & Wang, D. (2024) · BMC Public Health · doi:10.1186/s12889-024-18138-0 · Cited by 14
“All these factors are associated with the occurrence of sarcopenia [2, 37].”
BackgroundSharma, A. R., Chatterjee, S., Lee, Y., & Lee, S. (2023) · Aging and Disease · doi:10.14336/ad.2023.00903 · Cited by 30
“Thus, knowing the precise molecular mechanism involved in sarcopenia is essential [19].”
BackgroundFeng, Y., Wang, L., Guo, F., Zhu, F., Shi, J., Wang, Y., Zhang, Y., Chen, X., & Zhang, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27282 · Cited by 16
“Sarcopenia exacerbates inflammation through a vicious, cyclic increase in the pro-inflammatory cytokines TNF-α , IL-1 β , and IL-6 [17].”
BackgroundKono, Y., Kajita, H., Okada, T., Nakagawa, R., Fujita, T., & Konishi, S. (2022) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b22-00118 · Cited by 11
Tan, Y., Ye, Y., Huang, C., Li, J., Huang, L., Wei, X., Liang, T., Qin, E., Xiong, G.-L., & Bin, Y.-F. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s497631 · Cited by 14
“14,15 Our previous study found that local inhibition of TNF-α did not reverse skeletal muscle atrophy, suggesting that systemic sources of TNF-α also play an important role.”
Liu, S., Zhuang, S., Li, M., Zhu, J., Zhang, Y., & Hu, H. (2022) · Psychogeriatrics · doi:10.1111/psyg.12908 · Cited by 12
Córdova, A., Caballero-García, A., Noriega, D. C., Bello, H. J., Pons, A., & Roche, E. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19105938 · Cited by 11
“In this context, physical fitness is instrumental in the process of muscle regeneration and repair, essential to delay sarcopenia [3].”
BackgroundSelf-citationLiu, R., Xy, G., & Li, W. (2024) · BMC Public Health · doi:10.1186/s12889-024-18493-y · Cited by 11
“The reduction in muscle mass observed in sarcopenia within skeletal muscle mitochondria, suppress ubiq-uitin-proteasome system (UPS) activity, enhance the expression of autophagy-related genes, improve mitochondrial oxidative capacity, and increase muscle blood flow [35–37].”
BackgroundZhang, Y., Wu, Q., Wang, Y., Chen, Q., Han, S., Li, B., Zhao, Q., Wang, Q., Wang, Y., & Gao, Y. (2025) · Interactive Journal of Medical Research · doi:10.2196/64456 · Cited by 9
“Future research should focus on understanding the molecular mechanisms of various autoimmune diseases combined with sarcopenia and developing targeted therapies [108].”
Network pharmacology-based analysis of the effects of puerarin on sarcopenia
Chen, X., Wang, Y., Liu, M., Song, X., Wang, D., & Zhang, J. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-2360 · Cited by 7
“The pathogenesis of sarcopenia is associated with inflammation (23-25), oxidative stress (26,27), and myocyte apoptosis (28-30), and puerarin has anti-inflammatory, anti-oxidant, and apoptosisregulating effects (31).”
BackgroundA bibliometric analysis of inflammation in sarcopenia from 2007 to 2022
Zhang, Y., Zhao, Y., Rong, J., Liu, K., Zhan, Y., Chai, Y., Ning, J., & Yuan, W.-A. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112316 · Cited by 10
“Several epidemiological surveys have shown that aging is the pathological basis of sarcopenia and the aging process is often accompanied by chronic low-grade inflammation (Larsson et al., 2019; Pascual-Fern ´ andez et al., 2020).”
BackgroundO’Leary, M. F., Greed, E., Pritchard, J., Struszczak, L., Bozbaş, E., & Bowtell, J. L. (2024) · Experimental Physiology · doi:10.1113/ep092328 · Cited by 8
“…inflammation, obesity, insulin resistance, altered satellite cell function, anabolic resistance, altered ion handling, epigenetic changes, mitochondrial dysfunction, altered neuromuscular processes and lower motor neuron loss (Antoun et al., 2022; Pascual-Fernández et al., 2020; Tan et al., 2020).”
Karlsson, M., Becker, W., Cederholm, T., & Byberg, L. (2021) · British Journal Of Nutrition · doi:10.1017/s0007114521003901 · Cited by 9
“Mechanisms may involve anti-oxidative (57) and anti-inflammatory (58) effects on skeletal muscle and ageing, potentially involving the phytochemical content of fruits and vegetables (56) or the acid – basebalance ofthe diet,asnet acid load has been reported tobeassociated withlossofmusclemass (59) .”
BackgroundGinevičienė, V., Pranckevičienė, E., Kilaitė, J., Mastavičiūtė, A., Dadelienė, R., Jamontaitė, I. E., Letukienė, A., Ahmetov, I. I., & Alekna, V. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1326764 · Cited by 10
“In addition some hallmarks of aging such as mitochondrial dysfunction, loss of proteostasis and inflammatory disturbances are the key mechanisms currently understood to be involved in PFS development (11, 26, 27, 44, 47, 48, 51, 52).”
BackgroundInfluentialYing, H., Chen, Y., Hong, Y., Ying, K., Li, S., Zhang, Y., Mei, T., Song, X., He, Y., Yao, C., et al. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2440114 · Cited by 7
“…is known as a syndrome that is prone to fracture, joint injury, and even organ injuries due to the continuous decrease in skeletal muscle mass, strength and function [9]. sarcopenia is related to various diseases, such as auto-immune diseases, rheumatic diseases, aging, and disability [10–12].”
Bibliometric analysis of “sarcopenia” in Web of Science
Koca, T. T. (2023) · Egyptian Rheumatology and Rehabilitation · doi:10.1186/s43166-023-00194-w · Cited by 6
“Sarcopenia decreases the quality of life in relation to the decrease in self-care [9, 10].”
BackgroundMakino, T., Izumi, K., Iwamoto, H., Kadomoto, S., Kadono, Y., & Mizokami, A. (2023) · In Vivo · doi:10.21873/invivo.13209 · Cited by 6
Li, Y., Jin, S., Zhou, S., Xu, L., Jiang, C., Xu, Y., Qi, L., & Hu, S. (2025) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2025.105834 · Cited by 6
Autophagy selectively clears ER in TNF-α-induced muscle atrophy
Dueren, U. K., Wei, A. A. J., Gressler, A. E., Rapp, S., Popp, O., Kerridge, R., Buonomo, V., Grumati, P., Mertins, P., Selbach, M., et al. (2026) · Autophagy Reports · doi:10.1080/27694127.2026.2649064 · Cited by 6
“It also plays a role in chronic muscle-wasting diseases like cachexia [13,14] and age-related sarcopenia [15–17].”
Prevalence, associated factors, and impact of vitamin B12 deficiency in older medical inpatients
Papakitsou, I., Papazachariou, A., & Filippatos, T. D. (2024) · European Geriatric Medicine · doi:10.1007/s41999-024-01093-9 · Cited by 7
“Through modifications in strength and function, sarcopenia may reduce self-sufficiency of older adults [70] and increase the risk of falls and fractures [71, 72].”
Predictive models of sarcopenia based on inflammation and pyroptosis-related genes
Li, X., Wu, C., Lu, X., & Wang, L. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1491577 · Cited by 6
FRAGILIDADE CLÍNICO-FUNCIONAL E SARCOPENIA EM IDOSOS NA ATENÇÃO PRIMÁRIA À SAÚDE
de Carvalho, L. J. A. R., Mota, M. D. S., Muniz, T. M. S., Silva, R. C. D. S., Silva, A. D. S., & Machado, A. L. G. (2022) · Cogitare Enfermagem · doi:10.5380/ce.v27i0.76145 · Cited by 38
Larsson, L. E., Wang, R., Cederholm, T., Wiggenraad, F., Rydén, M., Hagman, G., Hellénius, M.-L., Kivipelto, M., & Thunborg, C. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221186 · Cited by 6
“Possiblemechanismsincludeinflammation andperipheralneurodegenerationrelatedtoenergy metabolism,oxidativestress,glucosemetabolism, tissuerepair,andgrowthfactorresponse,allofwhich areimportantinprotectingfromcognitiveandphys-ical decline [50].”
Jin, H., Seo, H. S., Shin, J., Lee, K.-J., Kim, S. J., Jung, S. H., & Kim, B. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177265 · Cited by 4
Fernández, A. C., Castellano, J. R., Caballero, E. R., Morales-Díaz, S., & Delgado-Plasencia, L. J. (2025) · Updates in Surgery · doi:10.1007/s13304-025-02273-3 · Cited by 4
Pang, E., Zou, Y., Lu, K., Li, J., Chen, X., Zhu, Y. M., Wang, T., Shi, L., & Kang, H. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1783596 · Cited by 3
Serum Myostatin among Excessive Drinkers
Martín‐González, C., Pérez‐Hernández, O., Rodríguez, A. G., Abreu-González, P., Toledo, P. O., Fernández-Rodríguez, C. M., Alvisa-Negrín, J. C., Martínez-Riera, A., & González‐Reimers, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032981 · Cited by 4
“A high proportion of these patients also show osteoporosis and altered body fat distribution [9], although controversy exists regarding the prevalence of obesity among excessive drinkers [10] Among alcoholics, muscle atrophy may be due to the combined effects of proinflammatory cytokines, peroxidative damage, ethanol-…”
BackgroundReflexiones de la prescripción de ejercicio físico en la consulta del médico familiar
Vilchis, M. A. T. (2023) · Revista Mexicana de Medicina Familiar · doi:10.24875/rmf.22000069 · Cited by 3
Kumar, P., Umakanth, S., Bruyère, O., & Girish, N. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e42174 · Cited by 4
Najm, A., Bîrcă, A. C., Niculescu, A.-G., Alberts, A., Grumezescu, A. M., Gălățeanu, B., Vasile, B. Ş., Beuran, M., Gașpar, B. S., Turculeţ, C. Ş., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125594 · Cited by 2
“Therefore, controlling the H 2 O 2 levels is essential in managing the oxidative stress associated with sarcopenia [15,21,22].”
Lu, Y., Bai, Y., Li, W., Zhou, Z., Lai, H., Hu, X., Yang, T., Wang, C., Chen, Y., Gan, K., et al. (2025) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.70052 · Cited by 2
Irisin, Brain-Derived Neurotrophic Factor (BDNF), and Redox Balance in Geriatric Dynapenia
Wojszel, A., Śliwowski, J., Rentflejsz, J., Rogalska, J., Brzoska, M. M., & Wojszel, Z. B. (2025) · Antioxidants · doi:10.3390/antiox14101268 · Cited by 5
“Skeletal muscle is particularly susceptible to oxidative stress-related damage and dysfunction because it is an organ characterized by a high metabolic rate [37,38].”
Hashmi, M. A., Verma, S., Math, R. G. H., Muralidharan, S., Pranesh, G., Sahana, M. P., Hariharan, N., C, M., Kamath, V., Yaligod, V., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-35476-8 · Cited by 2
Protective effects of irisin in sarcopenia: a promising treatment
Chen, Y., Li, G., Gao, F., Li, R., Yang, M., Ge, Y., & Wu, X. (2026) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2026.101090 · Cited by 3
“In the process of muscle injury repair, satellite cells will undergo three processes, from quiescence to activation, enter the cell cycle for proliferation, differentiate and fuse to form multinucleated myotubes and activate protein synthesis [100].”
InfluentialXiao, Q., Chen, Y.-H., Chen, Y., Chien, Y.-S., Hsieh, L., Shirakawa, H., & Yang, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108845 · Cited by 2
“EGF, involved in satellite cell proliferation, is crucial for muscle mass maintenance [62,63].”
BackgroundKalantarhormozi, M., Afshar, A., Hajeb, F., Bahreini, R., & Afshari, N. (2024) · Медицинский журнал Западного Казахстана · doi:10.18502/wkmj.v66i3.16629 · Cited by 2
“Boosting BDNF production by the brain could potentially strengthen muscle activity and delay the onset of sarcopenia [58, 68].”
BackgroundShavkuta, G. V., Лазебник, Л. Б., & Туркина, С. В. (2025) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-229-9-119-125 · Cited by 2
The Future of Drugs in Sarcopenia
Zazzara, M. B., Penfold, R., & Onder, G. (2021) · Practical issues in geriatrics · doi:10.1007/978-3-030-80038-3_14 · Cited by 4
Sarkopeni’ye Genel Bakış ve İlişkili Faktörler
Koca, T. T., & Yıldız, B. T. (2023) · Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi · doi:10.17517/ksutfd.1225196 · Cited by 3
Sarcopenia, sarcopenic obesity and osteoarthritis
Dedukh, N. V., Zaverukha, N. V., Bystrytska, M. А., & Yakovenchuk, N. (2021) · ORTHOPAEDICS TRAUMATOLOGY and PROSTHETICS · doi:10.15674/0030-598720213101-106 · Cited by 1
“as a result the regulation of metabolic processes at the molecular, cellular and organism levels is possible [36, 37].”
BackgroundAge- and sex-related development of osteosarcopenia in the aging Octodon degus rodent model
Gallo-Soljancic, P., Stefano, M. E. D., Lucas-Ochoa, A.-M., Sánchez-Rodrigo, C., Cuenca-Bermejo, L., Cuello, A. M. G., Fernández‐Villalba, E., & Herrero, M. T. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1486670 · Cited by 1
Asano, K., Tachibana, K., Shinoda, S., & Nakamura, T. (2025) · Supportive Care in Cancer · doi:10.1007/s00520-025-09751-9 · Cited by 3
“The predictors of sarcopenia development include low nutritional status, muscle composition changes, and muscle signaling [15].”
Mechanistic Insights into Jianpi Recipe's Amelioration of Sarcopenia Via miRNA Modulation
Lin, H., Wu, Y., Zhang, G., Chen, Z., Wu, Y., Lin, Y., & Wu, J. (2025) · Current Traditional Medicine · doi:10.2174/0122150838421384250811103712 · Cited by 1
Luruihui, L., Jing, X., Yuan, T., Wenming, L., Tan, T., Yuxuan, J., Bingyan, C., Hanzhi, Z., Danqiang, A., Yufan, Z., et al. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1757862 · Cited by 1
Exerkine-loaded exosomes in muscle aging: a nexus of exercise, regeneration, and crosstalk
Li, Y., Wu, Q., Wang, J., Ding, J., & He, J. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1706977 · Cited by 1
Mercier-Guery, A., Millet, M., Croset, M., Marcangeli, V., Dulac, M., Carvalho, L. P., Hajj‐Boutros, G., Gaudreau, P., Morais, J. A., Gouspillou, G., et al. (2026) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.70267 · Cited by 1
Tauroursodeoxycholic acid (TUDCA) ameliorates age‐related skeletal muscle loss
Carvalho, M. U. W. B. D., Barssotti, L., dos Santos, L. M. B., Rosa, L. R. D. O., Gomes‐Marcondes, M. C. C., CARNEIRO, E. M., Barbosa, H. C. L., & Zangerolamo, L. (2026) · The Journal of Physiology · doi:10.1113/jp290683 · Cited by 2
Liu, X., Li, H., Zuo, W., Wang, G., Jiang, J., Li, Z., He, X., Wang, W., Yue, Y., Yang, Z., et al. (2026) · The journal of nutrition health & aging · doi:10.1016/j.jnha.2026.100904 · Cited by 1
Protein and Energy Supplements for the Elderly
Hardiany, N. S., Agusta, I., Dewi, S., Iswanti, F. C., & Paramita, R. (2023) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-26576-1_14 · Cited by 1
Association between patients with migraine and sarcopenia: A retrospective study
Lee, D. A., Lee, H., Kim, J., & Park, K. M. (2024) · Medicine · doi:10.1097/md.0000000000038941 · Cited by 1
“[4,16] Furthermore, evidence has demonstrated that the concentration of CGRP increases post-synaptically in animal experimental models with aging, resulting in changes in maintenance of neuromuscular junctions.”
BackgroundMahmoodi, M., Mansouri, F., Makhtoomi, M., Shateri, Z., & Nouri, M. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1006106 · Cited by 1
Associations between sarcopenia with asthmatic prevalence, lung function and comorbidityPreprint
Hu, Z., Tian, Y., Song, X., Zeng, F., & Yang, A. (2022) · Research Square · doi:10.21203/rs.3.rs-1223134/v1
ABORDAGEM NUTRICIONAL DA SARCOPENIA SECUNDÁRIA A INSUFICIÊNCIA CARDÍACA EM IDOSOS
Rocha, B. O., Faustino, E. C. S., Rolla, M. E. S., & Stracieri, A. P. M. (2023) · ÚNICA CADERNOS ACADÊMICOS · doi:10.53426/unicad-2023.v1n1.001 · Cited by 1
Identification and validation of ferroptosis-Related genes in sarcopeniaPreprint
Chen, Y., Zhang, Y., Zhang, S., & Ren, H. (2023) · Research Square · doi:10.21203/rs.3.rs-3122342/v1
Metadata
- Authors
- Pascual-Fernández, J., Fernández-Montero, A., Córdova-Martínez, A., Pastor, D., Martínez-Rodríguez, A., & Roche, E.
- Affiliations
- Medical Extrahospital Emergency Service of Navarra, 31500 Pamplona, Spain
- Prevention and Health Service, University Clinic of Navarra, 31008 Pamplona, Spain
- Biochemistry, Molecular Biology and Physiology, Faculty of Health Sciences, GIR Physical Exercise and Aging, University of Valladolid, Campus Duques de Soria, 42004 Soria, Spain
- Universitat de Miguel Hernández d'Elx (ES)
- University of Alicante (ES)
- Corresponding author
- Roche, Enrique
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-11-22
- Volume
- 21
- Issue
- 22
- Pages
- 8844
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7700275
- OpenAlex
- W3108240984
- Cited by
- 125
- References
- 112
- Citations by year
- 2026: 24 · 2025: 24 · 2024: 24 · 2023: 23 · 2022: 20 · 2021: 10
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Valladolid Documentary Repository (University of Valladolid) (submittedVersion, cc-by)
- Deposito Adademico Digital Universidad De Navarra (University of Navarra) (submittedVersion, cc-by)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Repositorio Institucional de la Universidad de Alicante (Universidad de Alicante) (submittedVersion, cc-by)
- Funders
- ISABIAL (190290)
- Institute of Health Carlos III (CB12/03/30038)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Keywords
- sarcopenia, aging, muscle mass loss, muscle strength, physical activity, molecular pathways, cellular mechanisms, endocrine alterations, dietary factors, sedentary lifestyle, intervention targets, older adults
- MeSH terms
- Aging, Humans, Inflammation, Signal Transduction, Oxidative Stress, Muscle, Skeletal, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.